Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009615/ https://www.ncbi.nlm.nih.gov/pubmed/33798462 http://dx.doi.org/10.1016/S2213-8587(21)00059-0 |
_version_ | 1783672910864449536 |
---|---|
author | Schernthaner, Guntram |
author_facet | Schernthaner, Guntram |
author_sort | Schernthaner, Guntram |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8009615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80096152021-03-31 Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? Schernthaner, Guntram Lancet Diabetes Endocrinol Comment Elsevier Ltd. 2021-05 2021-03-30 /pmc/articles/PMC8009615/ /pubmed/33798462 http://dx.doi.org/10.1016/S2213-8587(21)00059-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Schernthaner, Guntram Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? |
title | Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? |
title_full | Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? |
title_fullStr | Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? |
title_full_unstemmed | Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? |
title_short | Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes? |
title_sort | can glucose-lowering drugs affect the prognosis of covid-19 in patients with type 2 diabetes? |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009615/ https://www.ncbi.nlm.nih.gov/pubmed/33798462 http://dx.doi.org/10.1016/S2213-8587(21)00059-0 |
work_keys_str_mv | AT schernthanerguntram canglucoseloweringdrugsaffecttheprognosisofcovid19inpatientswithtype2diabetes |